$0.2475
-0.00025-0.1%
Last update: Oct 23, 1:29 PM
IGC Pharma Inc (IGC) Stock Price, Quote, News & History
IGCAMEX
IGC Pharma shares encouraging interim data from Phase 2 trial of IGC-AD1 for Alzheimer's agitation. Results suggest significant reduction in agitation with...
You can purchase shares of IGC Pharma (AMEX:IGC) through any online brokerage.
Other companies in IGC Pharma’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
IGC Pharma has a consensus price target of $4.75.
The stock price for IGC Pharma (AMEX: IGC) is $0.24745 last updated October 23, 2026 at 1:29 PM EDT.
There are no upcoming dividends for IGC Pharma.
IGC Pharma does not have any upcoming earnings scheduled.
There is no upcoming split for IGC Pharma.
IGC Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the AMEX.
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets...
